Lee, An-Sheng
Sung, Yen-Ling
Pan, Szu-Hua
Sung, Kuo-Tzu
Su, Cheng-Huang
Ding, Shiao-Li
Lu, Ying-Jui
Hsieh, Chin-Ling
Chen, Yun-Fang
Liu, Chuan-Chuan
Chen, Wei-Yu
Chen, Xuan-Ren
Chung, Fa-Po
Wang, Shih-Wei
Chen, Che-Hong
Mochly-Rosen, Daria http://orcid.org/0000-0002-6691-8733
Hung, Chung-Lieh http://orcid.org/0000-0002-2858-3493
Yeh, Hung-I http://orcid.org/0000-0003-3206-0908
Lin, Shien-Fong
Article History
Received: 25 February 2022
Accepted: 26 May 2023
First Online: 6 June 2023
Competing interests
: This work was supported by research grants from the Mackay Memorial Hospital, Taipei, Taiwan. Declaration of competing interest: C.H. Chen and D. Mochly-Rosen hold patents related to ALDA-1 activation of <i>ALDH2*1</i> and <i>ALDH2*2</i>. One of the patents is licensed to Foresee Pharmaceuticals, a company where D. Mochly-Rosen is a consultant. However, the company did not contribute to any of the experiments included in the study. The other contributing authors claimed no conflicts of interest regarding the publication of these results.